PAM
Panagora Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-19,785
| Closed | -$742K | – | 1254 |
|
|
2023
Q1 | $742K | Hold |
19,785
| – | – | ﹤0.01% | 956 |
|
|
2022
Q4 | $554K | Sell |
19,785
-4,883
| -20% | -$137K | ﹤0.01% | 1119 |
|
|
2022
Q3 | $693K | Buy |
24,668
+16,382
| +198% | +$460K | ﹤0.01% | 1018 |
|
|
2022
Q2 | $288K | Sell |
8,286
-3,741
| -31% | -$130K | ﹤0.01% | 1315 |
|
|
2022
Q1 | $432K | Sell |
12,027
-17,938
| -60% | -$644K | ﹤0.01% | 1260 |
|
|
2021
Q4 | $698K | Buy |
+29,965
| New | +$698K | ﹤0.01% | 1079 |
|
|
2021
Q3 | – | Sell |
-7,916
| Closed | -$160K | – | 1728 |
|
|
2021
Q2 | $160K | Sell |
7,916
-1,276
| -14% | -$25.8K | ﹤0.01% | 1720 |
|
|
2021
Q1 | $168K | Hold |
9,192
| – | – | ﹤0.01% | 1763 |
|
|
2020
Q4 | $185K | Buy |
9,192
+1,276
| +16% | +$25.7K | ﹤0.01% | 1620 |
|
|
2020
Q3 | $148K | Buy |
+7,916
| New | +$148K | ﹤0.01% | 1639 |
|
|
2018
Q2 | – | Sell |
-31,820
| Closed | -$597K | – | 2369 |
|
|
2018
Q1 | $597K | Buy |
+31,820
| New | +$597K | ﹤0.01% | 1334 |
|
|
2017
Q1 | – | Sell |
-33,916
| Closed | -$625K | – | 2372 |
|
|
2016
Q4 | $625K | Sell |
33,916
-47,863
| -59% | -$882K | ﹤0.01% | 1369 |
|
|
2016
Q3 | $1.55M | Buy |
81,779
+51,281
| +168% | +$973K | 0.01% | 1023 |
|
|
2016
Q2 | $492K | Sell |
30,498
-15,741
| -34% | -$254K | ﹤0.01% | 1371 |
|
|
2016
Q1 | $555K | Sell |
46,239
-3,233
| -7% | -$38.8K | ﹤0.01% | 1317 |
|
|
2015
Q4 | $704K | Buy |
49,472
+14,835
| +43% | +$211K | ﹤0.01% | 1191 |
|
|
2015
Q3 | $405K | Buy |
34,637
+32,820
| +1,806% | +$384K | ﹤0.01% | 1387 |
|
|
2015
Q2 | $32K | Buy |
+1,817
| New | +$32K | ﹤0.01% | 2229 |
|